Erlotinib Derivative Inhibits Hepatocellular Carcinoma by Targeting CIP2A to Reactivate Protein Phosphatase 2A

Cell Death and Disease - United Kingdom
doi 10.1038/cddis.2014.325
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC


Related search